Commodity-TV

The whole world of commodities in one App!

Watch Management & Expert Interviews, Site-Visit-Videos, News Shows and receive top and up to date Mining Information on your mobile device worldwide!

Download our unique App for free!
Commodity-TV Play Store
Commodity-TV App Store
Commodity-TV

Social Media


Geopolitical tensions are increasing

Protests in Hong Kong against China, Iran confiscates oil tankers, Russia upgrades - not only the defence companies, but also suppliers in the food segment could benefit

Receive up-to-date information about the company directly via push notification

Recently Russia once again exhibited its missiles and other military vehicles. Saudi Arabia is upgrading and Turkey is also buying rocket systems from Russia and wants aircraft from the USA. And then there is China, whose military strength is becoming more and more remarkable. In the USA, these movements have not gone unnoticed. The military there is therefore hardly neglected. But not only new technologically sophisticated weapon systems belong to the equipment of a militant army.

Nutrition must also be perfected. Innovative companies such as EnWave - http://www.commodity-tv.net/c/search_adv/?v=299137 - can benefit from this. The Canadians have developed a unique system for drying food and pharmaceuticals. This is based on microwave technology and can dry the ingredients more quickly and gently. This has not escaped the attention of the U.S. military. Therefore, it has been working with EnWave for some time to develop field catering for the troops that is better than the previous one.

However, EnWave is not only on the move on military railways. On the contrary, this segment is rather small today. Currently, the application of the technology in the field of medical cannabis could become much more fruitful. This could speed up the development of medical products. Companies with activities in the cannabis sector, such as RavenQuest Biomed, benefit from this in turn.

RavenQuest BioMed - http://www.commodity-tv.net/c/search_adv/?v=299207 - owns cannabis acreage in Canada and the necessary sales license from Health Canada. RavenQuest BioMed is working with the Norwegian company Biocare to develop Europe as well. A large part of the expected high-quality harvest has already been sold. RavenQuest BioMed is not only active in production, but also in research, working with McGill University.

Current company information and press releases from EnWave (https://www.resource-capital.ch/en/companies/enwave-corp/) and RavenQuest BioMed (https://www.resource-capital.ch/en/companies/ravenquest-biomed-inc/).

In accordance with §34 WpHG, I would like to point out that partners, authors and employees can hold shares in the companies mentioned in each case and therefore there is a possible conflict of interest. Only the German version of these messages applies.

Disclaimer: The information provided does not constitute any form of recommendation or advice. We expressly point out the risks involved in securities trading. No liability can be assumed for damages resulting from the use of this blog. I would like to point out that shares and in particular warrant investments are generally associated with risk. The total loss of the invested capital cannot be excluded. All information and sources are carefully researched. However, no guarantee is given for the correctness of all contents. I expressly reserve the right to make a mistake, in particular with regard to figures and exchange rates, despite the utmost care. The information contained herein has been obtained from sources believed to be reliable but does not claim to be accurate or complete. Due to court rulings the contents of linked external sites are also to answer for (so among other things district court Hamburg, in the judgement of 12.05.1998 - 312 O 85/98), as long as no explicit dissociation from these takes place. Despite careful control of the contents, I do not assume any liability for the contents of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource Capital AG also applies: https://www.resource-capital.ch/en/disclaimer/

Always up to date with the newsletter from SRC

Swiss Resource Capital AG will use the information you provide in this form to keep in touch with you and to provide you with updates and marketing information. To receive our news, you still have to give us permission to send you E-Mails below.

You can change your mind at any time by clicking on the Unsubscribe link, which you can find in the footer of every email you receive from us, or by contacting us at [email protected] We will treat your information with care and respect. For more information about our privacy practices, visit our website. By clicking below, you agree that we may process your information in accordance with these Terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

* indicates required

Always up to date with the newsletter from SRC

Swiss Resource Capital AG will use the information you provide in this form to keep in touch with you and to provide you with updates and marketing information. To receive our news, you still have to give us permission to send you E-Mails below.

You can change your mind at any time by clicking on the Unsubscribe link, which you can find in the footer of every email you receive from us, or by contacting us at [email protected] We will treat your information with care and respect. For more information about our privacy practices, visit our website. By clicking below, you agree that we may process your information in accordance with these Terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

* indicates required